BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7835230)

  • 1. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
    Pochopin NL; Charman WN; Stella VJ
    Drug Metab Dispos; 1994; 22(5):770-5. PubMed ID: 7835230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients.
    Garg SK; Kumar B; Bakaya V; Lal R; Shukla VK; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):552-4. PubMed ID: 3243659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of proguanil on the pharmacokinetics of dapsone in healthy volunteers.
    Edstein MD; Rieckmann KH
    Chemotherapy; 1993; 39(4):235-41. PubMed ID: 8325124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.
    Lammintausta K; Kangas L; Lammintausta R
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):159-63. PubMed ID: 447435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic observations on dapsone in dermatitis herpetiformis.
    Swain AF; Ahmad RA; Rogers HJ; Leonard JN; Fry L
    Br J Dermatol; 1983 Jan; 108(1):91-8. PubMed ID: 6821646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of trimetrexate and dapsone in AIDS patients with Pneumocystis carinii pneumonia.
    Koda RT; Dubé MP; Li WY; Chatterjee DJ; Stansell JD; Sattler FR
    J Clin Pharmacol; 1999 Mar; 39(3):268-74. PubMed ID: 10073326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
    Edstein MD; Veenendaal JR; Rieckmann KH
    Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone.
    Kulkarni VM; Mishra DS
    Indian J Lepr; 1985; 57(4):756-62. PubMed ID: 3835207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute dapsone intoxication: a case with prolonged symptoms.
    Elonen E; Neuvonen PJ; Halmekoski J; Mattila MJ
    Clin Toxicol; 1979; 14(1):79-85. PubMed ID: 436385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pregnenolone 16alpha-carbonitrile on the pharmacokinetics and metabolism of dapsone in rats.
    Lu M; Poloyac SM; McNamara PJ; Blouin RA
    J Pharm Pharmacol; 1999 Jul; 51(7):803-10. PubMed ID: 10467955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
    Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
    J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
    Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatography determination of pyrimethamine, dapsone, monoacetyldapsone, sulfadoxine, and N-acetyl-sulfadoxine after rapid solid-phase extraction.
    Eljaschewitsch J; Padberg J; Schürmann D; Ruf B
    Ther Drug Monit; 1996 Oct; 18(5):592-7. PubMed ID: 8885125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of dapsone and monoacetyldapsone in rats.
    Gordon GR; Peters JH; Ghoul DC; Murray JF; Levy L; Biggs JT
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):485-92. PubMed ID: 1208566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylation polymorphism of dapsone in a Japanese population.
    Horai Y; Ishizaki T
    Br J Clin Pharmacol; 1988 Apr; 25(4):487-94. PubMed ID: 3382590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic method with ultraviolet detection for the determination of dapsone and its hydroxylated metabolite in human plasma.
    Kwadijk S; Toraño JS
    Biomed Chromatogr; 2002 May; 16(3):203-8. PubMed ID: 11920946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of dapsone and monoacetyldapsone in the dog (38516).
    Peters JH; Gordon R; Biggs JT; Levy L
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):251-5. PubMed ID: 1129265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man.
    Edstein MD; Rieckmann KH; Veenendaal JR
    Br J Clin Pharmacol; 1990 Aug; 30(2):259-65. PubMed ID: 2206787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.